Smith Group Asset Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Smith Group Asset Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-302	Closed	-$438K	–	518
2015 Q3	$438K	Buy	302 +104	+53%	+$201K	0.02%	197
2015 Q2	$438K	Buy	198 +18	+10%	+$56.4K	0.01%	191
2015 Q1	$537K	Buy	180 +12	+7%	+$38.4K	0.02%	195
2014 Q4	$554K	Buy	168 +1	+0.6%	+$3.54K	0.02%	202
2014 Q3	$588K	Hold	167	–	–	0.02%	197
2014 Q2	$643K	Buy	+167	New	+$628K	0.02%	196

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Smith Group Asset Management's FRTX Position: Q4 2015 in Review

Smith Group Asset Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2015, closing a stake of 302 shares — an estimated $438K sold.

Smith Group Asset Management first reported a position in FRTX in Q2 2014 and held it in 6 quarters. The position peaked at $643K in Q2 2014. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

Smith Group Asset Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
Smith Group Asset Management sold 302 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $438K.
Smith Group Asset Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2014 and held it in 6 quarters.
Smith Group Asset Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $643K in Q2 2014.
41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Smith Group Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.